Wozniak, Hannah
Tabah, Alexis
De Waele, Jan J.
Timsit, Jean-François
Buetti, Niccolò http://orcid.org/0000-0002-8096-1834
,
,
,
,
,
Funding for this research was provided by:
University of Geneva
Article History
Received: 19 July 2024
Accepted: 19 August 2024
First Online: 31 August 2024
Declarations
:
: The study was approved by the ethics Committee of the Royal Brisbane & Women's Hospital Human Research (LNR/2019/QRBW/48376). Each study site then obtained ethical and governance approvals according to the local regulations in place.
: Initial ethical approval as a low-risk research project with waiver of individual consent was granted by the Human Research Ethics Committee of the Royal Brisbane & Women's Hospital, Queensland, Australia (LNR/2019/QRBW/48376). Each study site then obtained ethical and governance approvals according to national and/or local regulations.
: JDW has consulted for Roche Diagnostics, Menarini, MSD, Pfizer, ThermoFisher and Viatris (fees and honoraria paid to institution). JFT reported advisory boards participation for Merck, Gilead, Beckton-Dickinson, Pfizer, Shionogi, Roche diagnostic, Advanz Pharma, research grants from Merck, Pfizer, Thermofischer.